UK markets open in 3 hours 35 minutes
NIKKEI 225
38,189.54 -216.12 (-0.56%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.16 -0.77 (-0.94%) GOLD FUTURES
2,297.50 -5.40 (-0.23%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,098.49 -2,886.73 (-5.66%)
Journey Medical Corporation (DERM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.3300 |
| Open | 3.3400 |
| Bid | 3.5400 x 100 |
| Ask | 3.7700 x 100 |
| Day's range | 3.3400 - 3.7200 |
| 52-week range | 1.0200 - 8.1100 |
| Volume | |
| Avg. volume | 159,362 |
| Market cap | 73.55M |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings date | 20 May 2024 - 24 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.83 |
GlobeNewswireJourney Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Pla
GuruFocus.comDirector Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
Journey Medical Corp (NASDAQ:DERM) has reported an insider purchase according to the latest SEC filings.
Simply Wall St.Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
Journey Medical ( NASDAQ:DERM ) Full Year 2023 Results Key Financial Results Revenue: US$79.2m (up 7.5% from FY 2022...
© 2024 Yahoo. All rights reserved.